SCHEMBL21474596

SCHEMBL21474596

COC(=O)C1=C(Oc2ccccc2)c2cc(Cl)ccc2C1Cc1ccc(C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.42
LTB4R2 Q9NPC1 1/20 0.42
MAPK14 Q16539 1/20 0.39
EPHX2 P34913 1/20 0.38
HTT P42858 3/20 0.38
FFAR1 O14842 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
P2RX4 Q99571 1/20 0.38
CYP2D6 P10635 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
FFAR4 Q5NUL3 1/20 0.37
LMNA P02545 1/20 0.37
THRB P10828 1/20 0.37
P2RX3 P56373 2/20 0.36
NPY5R Q15761 1/20 0.36
PLA2G2A P14555 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21474595 0.71 TSHR (0.42) LTB4RLTB4R2HTTCYP3A4CYP2C9
SCHEMBL21474594 0.69 LTA4H (0.41) EPHX2HTTFFAR1NPSR1L3MBTL1
SCHEMBL21478277 0.68 CYP26A1 (0.39) LTB4RLTB4R2EPHX2HTTL3MBTL1
SCHEMBL21478274 0.65 SLC6A3 (0.39) LTB4RLTB4R2NPSR1LMNA
SCHEMBL21723102 0.64 ABL1 (0.54) HTTCYP3A4CYP2C9CYP2C19NPSR1
SCHEMBL30974620 0.62 L3MBTL1 (0.58) HTTCYP3A4CYP2C9CYP2C19P2RX4
SCHEMBL5362837 0.62 L3MBTL1 (0.58) HTTCYP3A4CYP2C9CYP2C19P2RX4
SCHEMBL21478254 0.62 MAOB (0.39) LTB4RLTB4R2POLBLMNA
SCHEMBL27915348 0.61 HTR2A (0.47) LMNA
SCHEMBL21474683 0.61 MAOB (0.40) LTB4RLTB4R2FFAR1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019199979-A1 ANTIBACTERIAL COMPOUNDS THE GENERAL HOSPITAL CORPORATION (US) 2019-10-17 WO disclosed